Aehr Test Systems, Inc. designs, manufactures, and sells advanced test and burn-in systems for semiconductor devices. The company specializes in wafer-level testing and burn-in solutions for high-power semiconductors like silicon carbide (SiC) and gallium nitride (GaN), as well as photonics and optical devices used in AI data centers and mobile computing. Its core products, such as the FOX-XP and FOX-NP systems, enable full-wafer contact testing for power semis and integrated circuits, positioning AEHR as a key player in the growing demand for reliable chip testing amid the AI and electric vehicle booms.
From what I see, AEHR's business model centers on high-margin equipment sales to chipmakers, with strong exposure to hyperscale data centers and AI infrastructure. This niche in burn-in testing—stabilizing devices before deployment—helps explain its recent stock price surge, as AI-driven demand amplifies the need for robust power and optical components.
Over the last 30 days, AEHR stock rocketed from a close of $37.15 to $93.72, marking a +152% gain. The movement was volatile and trend-driven, with sharp rallies on earnings and order announcements, accompanied by volume spikes exceeding 4 million shares. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
In the past quarter, shares advanced from $30.91 to $93.72, delivering a +203% increase. The quarter featured steady upward momentum with increased volatility in April, reflecting broader market trends in semiconductors and AI stocks.
The primary catalyst was Aehr's April 16 announcement of a record $41 million production order for its FOX-XP systems from a leading hyperscale AI customer, pushing second-half bookings over $92 million. This news triggered a multi-day surge, with shares jumping over 20% in a single session amid high volume.
Earlier, on April 7, Q3 fiscal 2026 results revealed revenue of $10.3 million (down 44% YoY, missing estimates) but beat EPS expectations and reported record $37.2 million in bookings and $50.9 million backlog, driven by AI and data center demand. This mixed report still lifted sentiment, with shares up 27% post-earnings.
Sector tailwinds from the AI chip rally and analyst focus on AEHR's photonics wins further amplified the price movement. One thing that stands out is how these developments align with patterns I've seen in Tickeron’s AI Pattern Search Engine.
The quarter's +203% rise stemmed from sustained AI infrastructure demand, with Aehr securing deals for high-power burn-in in data centers and silicon photonics. Early quarter gains built on prior momentum, but April's earnings and $41 million order provided the strongest push.
Macro factors like semiconductor recovery and hyperscaler capex for AI favored AEHR's specialized testing equipment. Institutional interest grew with the backlog surge, outweighing revenue softness from lumpy orders. Competitive edges in SiC/GaN testing solidified its position amid industry-wide chip demand.
I regularly visit Tickeron’s Trending AI Robots page to review the platform's top-performing AI-driven trading bots from a library of hundreds that analyze and trade thousands of tickers across various markets. These bots employ diverse strategies, including momentum, mean reversion, and pattern recognition, with performance metrics like win rate, profit factor, and Sharpe ratio highlighted for transparency. Curated based on recent success and relevance to current market trends, the section helps me identify bots suited to short-term trades or long-term portfolios—especially useful for stocks like AEHR in volatile tech sectors. Whether focusing on volatile tech stocks or stable sectors, it's a practical way to explore real-time rankings and backtested results for enhancing stock analysis and trading decisions.
Investors should monitor upcoming fiscal Q4 earnings for updates on order fulfillment and backlog conversion. Continued AI data center expansion, including photonics and power semi demand, remains key. Macro shifts in semiconductor capex, interest rates, and supply chain dynamics could influence sentiment. Watch for new customer wins, guidance on revenue ramp, and insider activity amid the rally. Risks include order lumpiness and competition in testing equipment. In my view, I'm watching this closely as AI momentum persists.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
AEHR saw its Momentum Indicator move above the 0 level on May 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 238 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for AEHR moved out of overbought territory on April 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on April 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AEHR broke above its upper Bollinger Band on May 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 55, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.697) is normal, around the industry mean (20.634). P/E Ratio (19.449) is within average values for comparable stocks, (130.860). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.951). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (69.444) is also within normal values, averaging (64.005).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment